Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
Rev Med Brux ; 25(4): A241-7, 2004 Sep.
Article in French | MEDLINE | ID: mdl-15516049

ABSTRACT

The principal pathophysiologic mechanisms accounting for most cases of angioedema are reviewed as for their clinical presentations owing to the involved process. The features of the cutaneous reactions induced by foods or drugs to which the subjects are allergic, are discussed. The particular case of the amoxicillines reactions as well as the mechanisms by whom the aspirin, the NSAIDs and the ACE inhibitors induce angioedema are reminded. The description of cases lived in clinical practice illustrates the work and demonstrates the importance of anamnesis in the diagnostic approach of this affection.


Subject(s)
Angioedema , Adolescent , Adult , Angioedema/diagnosis , Angioedema/drug therapy , Angioedema/immunology , Angioedema/physiopathology , Female , Humans , Male , Middle Aged
2.
Rev Med Brux ; 22(4): A330-7, 2001 Sep.
Article in French | MEDLINE | ID: mdl-11680197

ABSTRACT

Pain is a frequent problem in aged population and often undertreated despite undesirable effects such as depression, malnutrition, sleep disturbance, decreased socialization, impaired ambulation with increased risk of falls problems, adverse effects from multiple inadequate drugs prescriptions, cognitive and behaviour impairments. Detection, diagnosis of the causes, evaluation with specific scales and adapted therapy of pain are essential to preserve quality of life and autonomy. Pharmacological therapy using the three-step analgesic ladder of W.H.O. is appropriate owing to individual age-related sensitivity which requires to follow the rule of "start low and go slow" with regular pain and side effects assessments, particularly for opioids. For chronic pain, non pharmacological strategies optimise pain management in addition to medications. Comprehensive geriatric assessment is recommended to complete the global view of the frailed patient with the help of a multidisciplinary team.


Subject(s)
Geriatrics/methods , Pain Management , Pain/diagnosis , Aged , Aging/physiology , Aging/psychology , Analgesics/pharmacokinetics , Analgesics/therapeutic use , Chronic Disease , Clinical Protocols , Diagnosis, Differential , Drug Administration Schedule , Frail Elderly , Geriatric Assessment , Humans , Pain/epidemiology , Pain/etiology , Pain/psychology , Pain Measurement , Patient Care Team , Quality of Life , Risk Factors , Therapeutic Equivalency , World Health Organization
3.
Rev Med Brux ; 22(3): 152-60, 2001 Jun.
Article in French | MEDLINE | ID: mdl-11488082

ABSTRACT

Pain is frequent in communicative or no-communicative, ambulatory, institutionalized or hospitalized veterans. It is associated with severe comorbidity so much more than chronic pain could be neglected and expressed of atypical manner or masked by the absence of classical symptoms in particular in case of dementia or of sensory disorders. Pain detection by clinic examination or by pain assessment's methods and adequate approach by pharmacological and non pharmacological therapies are essential for correct pain management. On pharmacological plan, the strategy of the O.M.S. landings is applicable owing to a more particular attention to secondary effects and drugs interactions. AINS must be manipulated with prudence. There are no reasons to exclude opioides from the therapeutic arsenal but with a reduction of the starting doses, a regular adaptation and a very attentive survey. In drugs of landing 2, tramadol reveals itself as efficient and better tolerated as the codeine and dextropropoxyphene has to be to avoid. The obtaining of a satisfactory result depends on a regular assessment of the pain in a context of polydisciplinar approach (physicians, nurses, paramedicals, other care givers).


Subject(s)
Geriatrics/methods , Pain Management , Pain/diagnosis , Aged/physiology , Aged/psychology , Analgesics/therapeutic use , Attitude to Health , Chronic Disease , Communication , Comorbidity , Drug Interactions , Geriatric Assessment , Humans , Pain/classification , Pain/etiology , Pain/physiopathology , Pain Measurement , Patient Care Team , Risk Factors , Therapeutic Equivalency
4.
Blood ; 96(13): 4285-92, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11110703

ABSTRACT

A recent study identified a clonal expansion of CD3(-)CD4(+)cells secreting Th2-type cytokines in 4 patients with chronic hypereosinophilia. Because interferon alpha (IFN-alpha) is used in the therapy of the idiopathic hypereosinophilic syndrome, the effects of this cytokine on the survival of clonal Th2 cells isolated from the blood of 2 patients were determined. First, these cells displayed a high rate of spontaneous apoptosis on culture in cytokine-free medium and were also sensitive to Fas-mediated apoptosis induced by soluble Fas ligand. Addition of IFN-alpha or interleukin-2 (IL-2) to culture medium resulted in significant protection against spontaneous but not Fas-induced apoptosis. Although spontaneous apoptosis of the clonal Th2 cells was clearly associated with down-regulation of both bcl-2 and bcl-x(L) levels, IFN-alpha had no significant effect on the expression of these antiapoptotic proteins, whereas addition of IL-2 resulted in higher levels of bcl-2. On the other hand, IFN-alpha decreased the numbers of cells with disrupted mitochondrial transmembrane potential both during spontaneous apoptosis and after exposure to protoporphyrin IX. Thus, IFN-alpha might promote the survival of clonal Th2 cells, an effect that could be relevant to the therapeutic approach for patients with chronic hypereosinophilia caused by clonal expansion of Th2-type cells. (Blood. 2000;96:4285-4292)


Subject(s)
Apoptosis/drug effects , Hypereosinophilic Syndrome/immunology , Interferon-alpha/pharmacology , Th2 Cells/drug effects , Adult , Cells, Cultured , Chronic Disease , Clone Cells/drug effects , Fas Ligand Protein , Female , Gene Expression Regulation , Genes, bcl-2 , Humans , Hypereosinophilic Syndrome/drug therapy , Hypereosinophilic Syndrome/pathology , Immunologic Memory , Immunophenotyping , Interferon alpha-2 , Interferon-alpha/therapeutic use , Interleukin-2/pharmacology , Intracellular Membranes/drug effects , Membrane Glycoproteins/pharmacology , Mitochondria/drug effects , Permeability/drug effects , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Protoporphyrins/pharmacology , Reactive Oxygen Species , Recombinant Proteins/pharmacology , Superoxides/metabolism , bcl-X Protein , fas Receptor/physiology
5.
Infect Control Hosp Epidemiol ; 21(10): 651-3, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11083182

ABSTRACT

We describe herein an outbreak of Enterobacter aerogenes in a geriatric acute unit with failure of contact isolation that necessitated the temporary closure of the department. We emphasize the need for guidelines for the management of multiresistant bacteria.


Subject(s)
Disease Outbreaks , Drug Resistance, Multiple , Enterobacter aerogenes/drug effects , Enterobacteriaceae Infections/transmission , Aged , Aged, 80 and over , Case-Control Studies , Electrophoresis, Gel, Pulsed-Field , Enterobacter aerogenes/isolation & purification , Enterobacteriaceae Infections/epidemiology , Female , Geriatrics , Humans , Length of Stay , Male , Risk Factors
6.
Br J Haematol ; 109(3): 540-8, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10886202

ABSTRACT

Idiopathic hypereosinophilic syndrome (HES) and Gleich's syndrome are related disorders characterized by persistent or recurrent hypereosinophilia of unknown origin. Elevated IgE levels and polyclonal hypergammaglobulinaemia are considered as markers of benign outcome in this setting as they are generally associated with predominant cutaneous manifestations and favourable response to glucocorticoid therapy. In a previous study, we identified a clonal population of CD3-CD4+ Th2-like lymphocytes secreting interleukin (IL)-5 and IL-4 in peripheral blood of a patient fulfilling the diagnostic criteria of HES with associated serum hyper-IgE. We now extend this observation by describing identical findings in three additional patients, and we compare their clinical and biological parameters with five other patients with HES. Chromosomal abnormalities were detected in purified CD3-CD4+ Th2 cells from three patients, among whom one developed anaplastic null cell lymphoma. We therefore suggest that a careful search for T-lymphocyte clonality and cytogenetic changes should be included in the work-up of HES for adequate management.


Subject(s)
Hypereosinophilic Syndrome/immunology , Th2 Cells/immunology , Adult , Case-Control Studies , Clone Cells , Female , Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor , Humans , Immunoglobulin E/blood , Immunophenotyping , Interleukin-13/analysis , Interleukin-4/analysis , Interleukin-5/analysis , Male , Middle Aged , Polymerase Chain Reaction
7.
Blood ; 94(3): 994-1002, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10419891

ABSTRACT

We recently observed a clonal expansion of CD3(-)CD4(+) T cells secreting Th2-type cytokines in patients presenting chronic hypereosinophilia. As clonal T cells isolated from such patients did not spontaneously secrete cytokines in vitro, we reasoned that costimulatory signals delivered by antigen-presenting cells might be required to induce their full activation. To address this question, we investigated in two such patients the responses of CD3(-)CD4(+) T cells to dendritic cells (DC). DC elicited proliferation and production of interleukin-5 (IL-5) and IL-13 by clonal cells from patient 1 and upregulated their expression of CD25 (IL-2R-alpha). These effects were abolished when blocking monoclonal antibodies (MoAbs) against IL-2R-alpha and IL-2 were added to cocultures, indicating critical involvement of an autocrine IL-2/IL-2R pathway. Cells from patient 2 were stimulated by DC to produce Th2 cytokines only when rIL-2 or rIL-15 was added to cocultures. In both patients, addition of inhibitory MoAbs against B7-1/B7-2 or CD2 to cocultures resulted in dramatic reduction of cytokine production and inhibited CD25 upregulation. Thus, TCR/CD3-independent activation of clonal Th2 cells by DC is an IL-2-dependent process, which requires signaling through CD2 and CD28.


Subject(s)
Cytokines/immunology , Eosinophilia/immunology , Receptors, Antigen, T-Cell/immunology , Th2 Cells/immunology , Adult , CD3 Complex , CD4 Antigens , Cell Differentiation/immunology , Clone Cells/immunology , Eosinophilia/pathology , Female , Humans , Lymphocyte Activation , Th2 Cells/pathology
8.
J Clin Invest ; 97(2): 309-15, 1996 Jan 15.
Article in English | MEDLINE | ID: mdl-8567949

ABSTRACT

The effects of recombinant IFN-alpha on the production of IL-5 by human CD4+ T cells were first analyzed on resting CD4+ T cells purified from normal PBMC and stimulated either with a combination of PMA and anti-CD28 mAb or anti-CD3 mAb cross-linked on B7-1/CD32-transfected mouse fibroblasts. We found that IFN-alpha profoundly inhibited in a dose-dependent manner IL-5 production by resting CD4+ T cells whereas IL-10 was upregulated in both systems. The addition of a neutralizing anti-IL-10 mAb to PMA and anti-CD28 mAb upregulated IL-5 production by resting CD4+ T cells but did not prevent IFN-alpha-induced IL-5 inhibition. We then analyzed the effect of IFN-alpha on the production of cytokines by differentiated type 2 helper (Th2) CD4+CD3- cells isolated from peripheral blood of two patients with the hypereosinophilic syndrome. In both cases, IFN-alpha markedly inhibited IL-5 production while it induced mild upregulation of IL-4 and IL-10. Finally, the inhibitory effect of IFN-alpha on IL-5 production was confirmed on a panel of Th2 and Th0 clones generated in vitro. In 2 out of 6 clones, IL-5 inhibition was associated with upregulation of IL-4 and IL-10. We conclude that IFN-alpha selectively downregulates IL-5 synthesis by human CD4+ T cells.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , Interferon-alpha/pharmacology , Interleukin-5/biosynthesis , Th2 Cells/metabolism , Animals , Base Sequence , CD28 Antigens/physiology , DNA Primers/chemistry , Gene Expression , Humans , Hypereosinophilic Syndrome/immunology , Interferon alpha-2 , Interleukin-10/biosynthesis , Interleukin-4/biosynthesis , Lymphocyte Activation , Mice , Molecular Sequence Data , Platelet Glycoprotein GPIIb-IIIa Complex/analysis , RNA, Messenger/genetics , Recombinant Proteins , Transfection
9.
Rev Med Brux ; 16(5): 368-71, 1995 Nov.
Article in French | MEDLINE | ID: mdl-7501914

ABSTRACT

In vitro lymphocyte mitogenic stimulation by phytohemagglutinin A was determined in 20 subjects, comparing tritiated thymidine incorporation and nuclear propidium iodide fluorescence. Unexpectedly, no correlation could be found between the two measures. The pitfalls of both methods are reviewed and discussed. The inability to validate one test by the other restricts the interpretation of the results obtained with one method and prevents their generalization. Without another gold-standard at the present time, specific and limited method-dependent norms should be defined.


Subject(s)
Lymphocyte Activation/drug effects , Propidium/pharmacology , Thymidine/metabolism , Fluorometry/methods , Humans , Iodine , Lymphocytes/metabolism , Propidium/analogs & derivatives , Tritium
10.
Acta Diabetol ; 31(1): 43-6, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8043897

ABSTRACT

The acute-phase reaction (APR) induces the production by the liver of short-lived glycoproteins. The carbohydrate moiety of these proteins is thought to interfere with the thiobarbiturate (TBA) and nitroblue tetrazolium colorimetric tests which are used for assaying non-enzymatic glycosylation (NEG) of serum proteins. The aim of the present study was to assess the effect of the APR on the specificity of the colorimetric tests in non-diabetic and diabetic subjects. A positive correlation was found between C-reactive protein (CRP), an APR glycoprotein, and non-specific TBA reactivity as determined after borohydride reduction (BH4-resistant TBA, BR-TBA), both in non-diabetics (r = 0.61; P < 0.01) and diabetics (r = 0.68; P < 0.01). The BH4-sensitive specific TBA (SP-TBA) was not influenced by glycoproteins, and its increase in diabetics was correlated with the nitroblue tetrazolium assay (r = 0.89; P < 0.01). An independent effect of diabetes and APR on non-specific TBA was also demonstrated, suggesting an effect of hyperglycaemia on both protein glycation and glycosylation. TBA with borohydride reduction is an attractive tool for the study of complex glycoproteins in diabetes.


Subject(s)
Acute-Phase Reaction/physiopathology , Diabetes Mellitus, Type 2/blood , Glycoproteins/biosynthesis , Hexosamines , Thiobarbiturates , Acute-Phase Reaction/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Blood Glucose , Borohydrides/metabolism , C-Reactive Protein/metabolism , Colorimetry/methods , Diabetes Mellitus, Type 2/physiopathology , Fructosamine , Glycosylation/drug effects , Hexosamines/blood , Humans , Middle Aged
11.
Acta Chir Belg ; 93(3): 115-8, 1993.
Article in English | MEDLINE | ID: mdl-8372583

ABSTRACT

Immune senescence is a multifaceted physiological syndrome of decline in the mechanisms of defence. Cofactors such as age-related associated diseases and malnutrition frequently seen in this category of the population, severely worsen the defect leading to the "immune compromised host" status. Frequency, morbidity and mortality of infections are undoubtedly largely influenced by such parameters. To date, adequate risk assessment and preventive medicine are the best approach to improve the chances of the elderly patient.


Subject(s)
Aging/immunology , Immunocompetence/immunology , Immunologic Deficiency Syndromes/immunology , Immunotherapy , Aged , Anti-Bacterial Agents/therapeutic use , Antibody Formation/immunology , Geriatrics , Humans , Immunity, Cellular/immunology , Immunologic Deficiency Syndromes/prevention & control , Immunologic Deficiency Syndromes/therapy , Nutritional Physiological Phenomena , Preventive Medicine
13.
Neuropsychobiology ; 25(2): 94-8, 1992.
Article in English | MEDLINE | ID: mdl-1625782

ABSTRACT

We studied 26 inpatients (17 females; mean age +/- SD: 41.2 +/- 14.3 years) who met the DSM III criteria for a major depressive episode and had a mean (+/- SD) Hamilton Depression Score of 19.3 +/- 8.0. All patients were drug free and medically healthy at the time of experimentation. We found a significant correlation between the CD4/CD8 ratio and the Hamilton Anxiety Score (r = 0.57, p less than 0.005). When splitting our sample in dexamethasone suppression test suppressors (DST-S) and nonsuppressors (DST-NS), this relationship appeared only in DST-NS (DST-NS: r = 0.81, p less than 0.005; DST-S: r = 0.20, p = NS). These results are discussed in terms of heterogeneity among major depressive disorders and possible relationships between catecholaminergic activity and the immune system.


Subject(s)
Adrenal Cortex Diseases/immunology , Anxiety/blood , Depressive Disorder/immunology , Lymphocyte Subsets/immunology , Adult , Anxiety/psychology , CD4 Antigens/blood , CD8 Antigens/blood , Depressive Disorder/psychology , Dexamethasone , Female , Humans , Hydrocortisone/blood , Male , Psychiatric Status Rating Scales
14.
Mech Ageing Dev ; 58(2-3): 127-38, 1991 May.
Article in English | MEDLINE | ID: mdl-1715005

ABSTRACT

In this cross-sectional clinical study, it was found that two subtypes of CD5+ B-lymphocytes existed either with CD5-high and CD20-low or CD5-low and CD20-high expression, as determined by dual fluorescence analysis with fluorochrome-labeled monoclonal antibodies on a FACScan flowcytometer. In the normal healthy subjects (n = 20), the CD20 positive cells could be broken down into 3 subsets: CD5(2+) CD20+, 25.4 +/- 3.0% (mean +/- S.E.M.), CD5+ CD20(2+), 18.4 +/- 2.4% and CD5- CD20(2+), 56.2 +/- 2.7%. Similar values were observed in a group of patients (n = 29) suffering from a wide variety of benign or untreated malignant disorders. The CD5(2+) CD20+ subset was typically related to age (Spearman coefficient of correlation rho = 0.77, P less than 0.001 in healthy subjects and rho = 0.46, P = 0.02 in pathological cases). The CD5+ CD20(2+) subpopulation was a salient feature of newborns and little infants (n = 6, 75.4 +/- 2.4%, P less than 0.01). The CD5- CD20(2+) subset was characteristically depressed in patients treated with cytotoxics (n = 21, 41.2 +/- 3.6%, P = 0.001). As far as cytotoxic chemotherapy may represent a model of accelerated ageing, it is worth noting that, in patients treated with cytotoxics, the CD5 CD20 pattern was frequently disturbed in a hyperyoung or hyperaged picture. That age and cytotoxics can affect CD5 expression on CD20+ lymphocytes, suggests some specific B-dysregulation and should be put together with the known emergence of autoantibodies, paraproteinemias and lympho-plasmocytic tumors with age and chemotherapy.


Subject(s)
Aging/physiology , Antineoplastic Agents/adverse effects , Lymphocyte Subsets/immunology , Adult , Aged , Aged, 80 and over , Antigens, CD , Antigens, CD20 , Antigens, Differentiation, B-Lymphocyte , CD5 Antigens , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Lymphocyte Subsets/drug effects , Lymphocyte Subsets/radiation effects , Male , Middle Aged , Neoplasms/drug therapy , Neoplasms/immunology , Neoplasms/radiotherapy
15.
Int J Neurosci ; 53(2-4): 53-62, 1990 Aug.
Article in English | MEDLINE | ID: mdl-1702407

ABSTRACT

Nine healthy volunteers received epinephrine and hydrocortisone intravenously in order to assess the typical acute response to a brief stress, of leukocyte and lymphocyte subsets, acute phase reactants and lymphocyte reactivity to T and B mitogens. At 10 min., all leukocyte subsets were increased, especially mononuclear cells. At 1 hour, moderate lymphopenia and monocytopenia occurred. At 6 hours, neutrophilia and eosinopenia were observed. During the lymphocytic early wave, all the lymphocyte subset counts increased, particularly T-suppressive/cytotoxic and natural killer cells. As a consequence, the percentage of T cells decreased and the CD4/CD8 ratio fell. No changes in acute phase reactants occurred over the 24 hours of the study. All leukocyte and lymphocyte subsets were normalized and mitogen reactivity was unchanged 24 hours after the stress. These typical shifts in leukocyte subsets could probe the adrenocortical and medullary response to an environmental stressor.


Subject(s)
Epinephrine , Hydrocortisone , Leukocytes/pathology , Lymphocyte Subsets/pathology , Stress, Physiological , Stress, Physiological/pathology , Acute-Phase Proteins/analysis , Adult , Female , Humans , Injections, Intravenous , Leukocyte Count/drug effects , Lymphocytes/drug effects , Male , Mitogens/pharmacology , Stress, Physiological/blood , Stress, Physiological/chemically induced , Time Factors
16.
Arch Gerontol Geriatr ; 6(2): 163-75, 1987 Jul.
Article in English | MEDLINE | ID: mdl-2957968

ABSTRACT

The mitogenic response of human lymphocytes and the short-lived suppressor cell function on concanavalin A response were studied as dependent variables in 194 patients using multiple regression analysis, with health status and sex as dummy variables, and age as an explicative one. This study confirms a decrease of the lymphocyte functional response to mitogens with aging. A sex-related defect in suppressor cell function is put forward in females independently of age. An inverse linear relationship is found between the functional response to pokeweed mitogen (T and B mitogen) and suppressor cell function in males but not in females. No such relationship is found with the pure T mitogens (Con A and phytohemagglutinin-A). The present study suggests that a defect in short-lived suppressor cells can play some role in the greater incidence and prevalence of autoimmune diseases in women while the depressed lymphocyte response of old people cannot be explained by modifications of the activity of these suppressor cells.


Subject(s)
T-Lymphocytes, Regulatory/immunology , Adult , Aged , Aging/immunology , Autoimmune Diseases/etiology , Female , Health Status , Humans , Immunity, Cellular , In Vitro Techniques , Lymphocyte Activation , Male , Middle Aged , Mitogens/pharmacology , Sex Factors
18.
Gerontology ; 32(2): 74-80, 1986.
Article in English | MEDLINE | ID: mdl-3486801

ABSTRACT

Using several models of multivariate analysis, it is found that age per se is a specific determinant on the in vitro lymphocyte response to phytohemagglutinin A in a random sample of 30 diseased patients. Depending upon the used model, sex and lymphocyte subsets appear as other significant variables. The multiple regression coefficients reach 0.85. A 2% fall per decade is expected for phytohemagglutinin A responsiveness expressed in 1n cpm.


Subject(s)
Aging , Phytohemagglutinins/pharmacology , T-Lymphocytes/drug effects , Adolescent , Adult , Age Factors , Aged , Animals , Erythrocytes/immunology , Female , Humans , Immunologic Capping , In Vitro Techniques , Lymphocyte Activation , Male , Middle Aged , Regression Analysis , Sex Factors , Sheep/immunology
19.
Cytobios ; 45(182-183): 139-46, 1986.
Article in English | MEDLINE | ID: mdl-3731875

ABSTRACT

Flunarizine, a slow-channel calcium entry blocker used as a vasodilator, interferes in vitro with human lymphocyte functions. It prevents lymphocytes from capping sheep erythrocytes, an effect which is probably due to the disconnection of the membrane from its cytoskeletal control. Flunarizine antagonizes both colchicine and cytochalasin B effects upon capping. Although the mitogen-induced lymphocyte stimulation has been shown to be sensitive to calcium depletion or calcium entry blocking by Verapamil, an enhanced response to phytohaemagglutinin A was observed with flunarizine. This suggests a differential sensitivity of the lymphocytes to calcium-entry blockers.


Subject(s)
Calcium Channel Blockers/pharmacology , Cinnarizine/analogs & derivatives , Lymphocytes/immunology , Animals , Cinnarizine/pharmacology , Cytochalasin B/pharmacology , DNA Replication/drug effects , Flunarizine , Humans , Lymphocyte Activation/drug effects , Lymphocytes/drug effects , Rosette Formation , Sheep , Thymidine/metabolism , Tritium
20.
Int J Immunopharmacol ; 8(8): 925-9, 1986.
Article in English | MEDLINE | ID: mdl-3804535

ABSTRACT

Dipyridamole is a potent inhibitor of tritiated thymidine incorporation by PHA-stimulated human lymphocytes. This effect is unrelated to the length of culture, to the level of response in untreated cultures, or to the proliferative index. This suggests that dipyridamole principally effects the membrane transport of thymidine. Dipyridamole inhibits sheep-erythrocyte-capping by E-rosettes. This effect cannot be mimicked by theophylline or cyclic nucleotides and cannot be reverted by adenosine. Pharmacological studies with colchicine and cytochalasin B suggest interference with cytoskeletal functions, probably of microtubules. This could be another site of action of dipyridamole beyond phosphodiesterase inhibition and adenosine metabolism.


Subject(s)
Dipyridamole/pharmacology , Immunologic Capping/drug effects , Lymphocytes/drug effects , Thymidine/metabolism , Erythrocytes/immunology , Humans , In Vitro Techniques , Lymphocyte Activation , Lymphocytes/immunology , Lymphocytes/metabolism , Phytohemagglutinins/pharmacology , Rosette Formation
SELECTION OF CITATIONS
SEARCH DETAIL